Xeris Biopharma Holdings (XERS) Interest Coverage Ratio (2020 - 2025)
Historic Interest Coverage Ratio for Xeris Biopharma Holdings (XERS) over the last 6 years, with Q3 2025 value amounting to 0.92.
- Xeris Biopharma Holdings' Interest Coverage Ratio rose 15578.24% to 0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33, marking a year-over-year increase of 12180.15%. This contributed to the annual value of 1.1 for FY2024, which is 3330.23% up from last year.
- Per Xeris Biopharma Holdings' latest filing, its Interest Coverage Ratio stood at 0.92 for Q3 2025, which was up 15578.24% from 0.61 recorded in Q2 2025.
- In the past 5 years, Xeris Biopharma Holdings' Interest Coverage Ratio ranged from a high of 0.92 in Q3 2025 and a low of 26.82 during Q4 2021
- In the last 5 years, Xeris Biopharma Holdings' Interest Coverage Ratio had a median value of 2.14 in 2023 and averaged 5.05.
- As far as peak fluctuations go, Xeris Biopharma Holdings' Interest Coverage Ratio plummeted by 53774.61% in 2021, and later soared by 15918.41% in 2025.
- Xeris Biopharma Holdings' Interest Coverage Ratio (Quarter) stood at 26.82 in 2021, then surged by 87.05% to 3.47 in 2022, then surged by 59.58% to 1.4 in 2023, then surged by 115.53% to 0.22 in 2024, then surged by 322.86% to 0.92 in 2025.
- Its last three reported values are 0.92 in Q3 2025, 0.61 for Q2 2025, and 0.42 during Q1 2025.